Search

Search Constraints

You searched for: Author/Creator Sullivan, L

Search Results

2. 263TiPATHENA (GOG-3020/ENGOT-ov45): A randomised, double-blind, placebo-controlled phase III study of the poly (ADP-ribose) polymerase (PARP) inhibitor rucaparib + the PD-1 inhibitor nivolumab following frontline platinum-based chemotherapy in ovarian cancer. (24th November 2019)

6. Effectiveness of a quality improvement collaborative in reducing time to surgery for patients requiring emergency cholecystectomy. Issue 6 (8th October 2019)